Vor Biopharma Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Vor Biopharma Inc. has filed 451 SEC EDGAR filings since 10 Jul 2020

SEC filing history

Showing 1-25 of 451 matching filings.

Per page
25
Current page
1
SCHEDULE 13G File 005-92269

SCHEDULE 13G filing

Filing date
06 Aug 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-92269

SCHEDULE 13G filing

Filing date
30 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-92269

SCHEDULE 13D/A filing

Filing date
21 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Jul 2026
Reporting date
16 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
09 Jul 2026
Reporting date
07 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 Jul 2026
Reporting date
07 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Jun 2026
Reporting date
11 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Jun 2026
Reporting date
11 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Jun 2026
Reporting date
11 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Jun 2026
Reporting date
11 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Jun 2026
Reporting date
11 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Jun 2026
Reporting date
11 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Jun 2026
Reporting date
11 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Jun 2026
Reporting date
11 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-92269

SCHEDULE 13G/A filing

Filing date
15 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-92269

SCHEDULE 13G/A filing

Filing date
15 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-295346

EFFECT filing

Filing date
06 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-92269

SCHEDULE 13G/A filing

Filing date
06 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-92269

SCHEDULE 13G/A filing

Filing date
06 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
04 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-295346

UPLOAD filing

Filing date
01 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .